The likely worst case scenario is that Hebang won't be allowed to raise their shareholding further (stage 2 of the placement), and will have to stick with what they have, or possibly reduce it to 20%. Hence the reason they offered the unsecured loan for stage 2 funds. They still need access to the resource, so would most likely continue with their plan and provide loans to AEV to build the YP plant and get things moving. They won't just pack up their bat and ball and go home.
Ann: Strategic Investment from Sichuan Hebang Biotechnology, page-225
Add AEV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $29.74M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.1¢ | $14.12K | 1.311M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2012302 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 996420 | 4 |
View Market Depth
| Last trade - 14.30pm 15/11/2024 (20 minute delay) ? |
| AEV (ASX) Chart |